BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 24127248)

  • 21. Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome.
    Schmeler KM; Lynch HT; Chen LM; Munsell MF; Soliman PT; Clark MB; Daniels MS; White KG; Boyd-Rogers SG; Conrad PG; Yang KY; Rubin MM; Sun CC; Slomovitz BM; Gershenson DM; Lu KH
    N Engl J Med; 2006 Jan; 354(3):261-9. PubMed ID: 16421367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-port risk-reducing salpingo-oophorectomy with and without hysterectomy: surgical outcomes and learning curve analysis.
    Escobar PF; Starks DC; Fader AN; Barber M; Rojas-Espalliat L
    Gynecol Oncol; 2010 Oct; 119(1):43-7. PubMed ID: 20579712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malignancies following bilateral salpingo-oophorectomy (BSO).
    Gotlieb WH; Barchana M; Ben-Baruch G; Friedman E
    Eur J Surg Oncol; 2006 Dec; 32(10):1231-4. PubMed ID: 16626923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interventions to reduce the risk of ovarian and fallopian tube cancer: A European Menopause and Andropause Society Postition Statement.
    Pérez-López FR; Ceausu I; Depypere H; Kehoe S; Lambrinoudaki I; Mueck A; Senturk LM; Simoncini T; Stevenson JC; Stute P; Rees M
    Maturitas; 2017 Jun; 100():86-91. PubMed ID: 28389043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
    Chow S; Raine-Bennett T; Samant ND; Postlethwaite DA; Holzapfel M
    Am J Obstet Gynecol; 2020 Dec; 223(6):900.e1-900.e7. PubMed ID: 32585221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Concurrent uterine surgery and uptake of hormone therapy in patients undergoing bilateral salpingo-oophorectomy for risk-reducing or therapeutic indications.
    Sasse SA; Lee SS; Rajeev P; Sharma SR; Kahan T; Pothuri B
    Gynecol Oncol; 2023 Dec; 179():131-137. PubMed ID: 37988946
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bone mineral density and fractures after risk-reducing salpingo-oophorectomy in women at increased risk for breast and ovarian cancer.
    Fakkert IE; Abma EM; Westrik IG; Lefrandt JD; Wolffenbuttel BH; Oosterwijk JC; Slart RH; van der Veer E; de Bock GH; Mourits MJ
    Eur J Cancer; 2015 Feb; 51(3):400-8. PubMed ID: 25532426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer Risk-Reducing Opportunities in Gynecologic Surgery.
    Piszczek C; Ma J; Gould CH; Tseng P
    J Minim Invasive Gynecol; 2018; 25(7):1179-1193. PubMed ID: 29097232
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prophylactic surgery in common hereditary cancer syndromes].
    Noguès C; Mouret-Fourme E
    Bull Acad Natl Med; 2012 Oct; 196(7):1237-45. PubMed ID: 23815011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Experience of risk-reducing salpingo-oophorectomy for a BRCA1 mutation carrier and establishment of a system performing a preventive surgery for hereditary breast and ovarian cancer syndrome in Japan: our challenges for the future.
    Hirasawa A; Masuda K; Akahane T; Tsuruta T; Banno K; Makita K; Susumu N; Jinno H; Kitagawa Y; Sugano K; Kosaki K; Aoki D
    Jpn J Clin Oncol; 2013 May; 43(5):515-9. PubMed ID: 23487443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prior hysterectomy and oophorectomy and incident venous thrombosis risk among postmenopausal women: a population-based, case-control study.
    Harrington LB; Weiss NS; Wiggins KL; Heckbert SR; McKnight B; Blondon M; Woods NF; LaCroix AZ; Psaty BM; Smith NL
    Menopause; 2016 Feb; 23(2):143-9. PubMed ID: 26757272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries.
    Ayhan A; Guvenal T; Salman MC; Ozyuncu O; Sakinci M; Basaran M
    Gynecol Oncol; 2005 Aug; 98(2):235-41. PubMed ID: 15982725
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Could fertility-sparing surgery be considered for women with early stage ovarian clear cell carcinoma?
    Nasioudis D; Chapman-Davis E; Frey MK; Witkin SS; Holcomb K
    J Gynecol Oncol; 2017 Nov; 28(6):e71. PubMed ID: 28758377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of hormone replacement therapy after risk-reducing salpingo-oophorectomy.
    Johansen N; Liavaag AH; Iversen OE; Dørum A; Braaten T; Michelsen TM
    Acta Obstet Gynecol Scand; 2017 May; 96(5):547-555. PubMed ID: 28236297
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis.
    Manchanda R; Burnell M; Abdelraheim A; Johnson M; Sharma A; Benjamin E; Brunell C; Saridogan E; Gessler S; Oram D; Side L; Rosenthal AN; Jacobs I; Menon U
    BJOG; 2012 Apr; 119(5):527-36. PubMed ID: 22260402
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The RANZCOG College Statement on prophylactic oophorectomy in older women undergoing hysterectomy for benign disease: is the evidence sufficient to change practice?
    Brand AH
    Aust N Z J Obstet Gynaecol; 2011 Aug; 51(4):296-300. PubMed ID: 21806570
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should ovaries be removed or not in early-stage cervical adenocarcinoma: a multicenter retrospective study of 105 patients.
    Hu J; Jiao X; Yang Z; Cui H; Guo H; Wu Y; Zhu L
    J Obstet Gynaecol; 2017 Nov; 37(8):1065-1069. PubMed ID: 28631536
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hysterectomy and Bilateral Salpingo-Oophorectomy: Variations by History of Military Service and Birth Cohort.
    Callegari LS; Gray KE; Zephyrin LC; Harrington LB; Gerber MR; Cochrane BB; Weitlauf JC; Bean-Mayberry B; Bastian LA; Mattocks KM; Haskell SG; Katon JG
    Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S67-77. PubMed ID: 26768393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oophorectomy and hysterectomy and cancer incidence in the Cancer Prevention Study-II Nutrition Cohort.
    Gaudet MM; Gapstur SM; Sun J; Teras LR; Campbell PT; Patel AV
    Obstet Gynecol; 2014 Jun; 123(6):1247-1255. PubMed ID: 24807324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of bilateral salpingo-oophorectomy at the time of hysterectomy on pelvic organ prolapse: results from the Women's Health Initiative trial.
    Shveiky D; Kudish BI; Iglesia CB; Park AJ; Sokol AI; Lehman AM; Shara N; Howard BV
    Menopause; 2015 May; 22(5):483-8. PubMed ID: 25423323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.